VO
Vor Biopharma Inc.
VOR · NASDAQ
$22.00 +0.78% (+$0.17)
1M -3.61%
Market Cap $1.19B
P/E Ratio 1.89x
Div. Yield -
ROE -
Bulios Fair Price
$15.83
28.0% downside
Current Price
$22
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VOR is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap EV/EBITDA 1.68x
P/E 1.89x
P/FFO N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
21 /100
Poor ROA 130.50%
Asset turnover 0.00x
ROIC 32.21%
Debt
100 /100
Low Net debt/EBITDA -0.16x
Current ratio 19.15x
Int. coverage N/A
Stability
11 /100
Unstable EPS volatility 70.85%
Profitable years 0
Beta 1.72x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VOR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Paul Kress
Employees
76
Headquarters
Boston
Upcoming events
12 NOV
Earnings
Upcoming earnings report